Oncologix Tech Inc. | 2013 | FY | 3


   August 31,  August 31,
   2013  2012
           
6.0% convertible note due September 2013 (1)  $235,025   $235,025 
           
           
Total unsecured related party convertible notes payable   235,025    235,025 
Less:  Current portion   (235,025)   —   
           
Long-term portion  $—     $235,025 
           
(1)  Note payable to former CEO who resigned 4/1/09 and still remains a director of our subsidiary.          

us-gaap:ScheduleOfDebtConversionsTextBlock